News Releases
| 2008 | |||
| 19/12/2008 | MERCK SERONO AQUIRES MANUFACTURING RIGHTS AND FACILITY FOR STIMUVAX FROM ONCOTHYREON Geneva, Switzerland | English | |
| 09/12/2008
| MERCK SERONO’S KUVAN® RECEIVES MARKETING AUTHORIZATION IN EUROPE | English German French | |
| 01/12/2008 | MERCK SERONO: EUROPEAN COMMISSION APPROVES ERBITUX FOR FIRST-LINE USE IN HEAD AND NECK CANCER
Geneva, Switzerland | English | |
| 13/11/2008 | MERCK SERONO: OVERALL SURVIVAL IN FIRST-LINE NSCLC REACHES 15 MONTHS WITH ERBITUX Geneva, Switzerland | English | |
| 12/11/2008 | MERCK SERONO LAUNCHES EXPANSION OF FLAGSHIP BIOTECH CENTER TO MEET GROWING PATIENT NEEDS Geneva, Switzerland | ||
| 29/10/2008 | MERCK SERONO’S US AFFILIATE EMD SERONO, INC. AND THERATECHNOLOGIES ANNOUNCE COLLABORATION AND LICENSING AGREEMENT FOR TESAMORELIN IN THE UNITED STATES | English German | |
| 29/10/2008 | MERCK SERONO AND LPATH FORM ALLIANCE FOR ASONEP Gerneva, Switzerland | English | |
| 24/10/2008 | MERCK SERONO SUBMITS APPLICATION FOR GONAL-F® IN JAPAN FOR OVULATION INDUCTION IN INFERTILE WOMEN Gerneva, Switzerland | English German French | |
| 24/10/2008 | MERCK SERONO: ERBITUX RECEIVES CHMP POSITIVE OPINION FOR FIRST-LINE USE IN HEAD AND NECK CANCER Geneva, Switzerland | English | |
| 14/10/2008 | MICHAEL J. FOX FOUNDATION AWARDS $2 MILLION GRANT FROM MERCK SERONO TO RESEARCH PROJECTS ON COGNITIVE DEFICITS IN PARKINSON´S DISEASE Geneva, Switzerland | English German French | |
| 10/10/2008 | MERCK SERONO NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE Geneva, Switzerland | English German French | |
| 03/10/2008 | SEVERE ADVERSE EVENT REPORTED IN RAPTIVA® PATIENT Geneva, Switzerland | English German French | |
| 01/10/2008 | MERCK SERONO AMONG THE WINNERS IN THE GERMAN BIOPHARMA STRATEGY COMPETITION Geneva, Switzerland | English German | |
| 29/09/2008 | MERCK SERONO RECOGNIZED FOR STRATEGIC LEADERSHIP IN HUMAN RESOURCES Geneva, Switzerland | English German French | |
| 26/09/2008 | MERCK SERONO´S KUVAN® RECOMMENDED FOR EUROPEAN APPROVAL Geneva, Switzerland | English German French | |
| 23/09/2008 | MERCK SERONO ANNOUNCES ONE-MONTH RESULTS OF PHARMACOGENOMICS STUDY PREDICT AT 47TH ANNUAL MEETING OF THE EUROPEAN SOCIETY FOR PAEDIATRIC ENDOCRINOLOGY Geneva, Switzerland | English German French | |
| 22/09/2008 | RESULTS FROM IMPROVE STUDY SHOW THERAPEUTIC EFFECT OF NEW FORMULATION OF REBIF® AT 16 WEEK IN PATIENTS WITH MULTIPLE SCLEROSIS
Geneva, Switzerland | ||
| 18/09/2008 | MERCK SERONO ANNOUNCES INITIATION OF THE ORACLE MS TRIAL TO EVALUATE CLADRIBINE TABLETSIN PATIENTS AT RISK OF DEVELOPING MULTIPLE SCLEROSIS Geneva, Switzerland | English German French | |
| 17/09/2008 | MERCK SERONO COMPLETES ENROLLMENT IN THE REFLEX TRIAL OF REBIF® IN PATIENTS AT RISK OF DEVELOPING MULTIPLE SCLEROSIS | English German French | |
| 11/09/2008 | MERCK SERONO SUBMITS NEW LICENSE APPLICATION FOR ERBITUX IN FIRST-LINE NON-SMALL CELL LUNG CANCER IN EUROPE Geneva, Switzerland | English | |
| 10/09/2008 | GLUCOPHAGE® POWDER FOR ORAL SOLUTION IN SACHET RECEIVES POSITIVE OPINION FOR APPROVAL IN EUROPE | English German French | |
| 04/09/2008 | MERCK SERONO AND ABLYNX ENTER INTO AN AGREEMENT TO CO-DISCOVER AND CO-DEVELOP NANOBODIES® Geneva, Switzerland | English German French | |
| 03/09/2008 | MERCK SERONO AND ZYMOGENETICS RESTRUCTURE PARTNERSHIP Geneva, Switzerland | English German French | |
| 23/07/2008 | MERCK SERONO RECEIVES EUROPEAN APPROVAL FOR BROADER USAGE OF ERBITUX IN METASTATIC COLORECTAL CANCER INCLUDING FIRST-LINE TREATMENT
Geneva, Switzerland | English | |
| 16/07/2008 | MERCK SERONO: ERBITUX APPROVED FOR USE IN METASTATIC COLORECTAL CANCER IN JAPAN Geneva, Switzerland | English | |
| 09/07/2008 | MERCK SERONO: ERBITUX® PHASE III CLINICAL STUDY IN GASTRIC CANCER STARTED Geneva, Switzerland | English | |
| 01/07/2008 | EMEA CONFIRMS POSITIVE BENEFIT-RISK BALANCE WITH RAPTIVA® FOR THE TREATMENT OF PSORIASIS
Geneva, Switzerland | English German French | |
| 19/06/2008 | MERCK SERONO APPLIES TO EXTEND USE OF ERBITUX FOR FIRST-LINE HEAD AND NECK CANCER IN EUROPE
Geneva, Switzerland | English | |
| 18/06/2008 | MERCK SERONO AND BIONOMICS ANNOUNCE MULTIPLE SCLEROSIS DEVELOPMENT AND LICENSING AGREEMENT
Geneva, Switzerland | English German French | |
| 18/06/2008 | RENOUVELLEMENT DE LA CERTIFICATION ENVIRONNEMENTALE DU SITE DE PRODUCTION DE MERCK SERONO À CORSIER-SUR-VEVEY Genève, Suisse | German French | |
| 10/06/2008 | MERCK SERONO STRENGTHENS ITS PRESCRIPTION MEDICINES PORTFOLIO IN LATIN AMERICA Geneva, Switzerland | English German French | |
| 10/06/2008 | MERCK SERONO’S REBIF® CELEBRATES 10TH ANNIVERSARY Geneva, Swizterland | English German French | |
| 05/06/2008 | MERCK SERONO ANNOUNCES INITIATION OF SECOND PHASE II/III CLINICAL STUDY OF ATACICEPT IN LUPUS
Geneva, Switzerland | English German French | |
| 01/06/2008 | MERCK SERONO: ERBITUX – ENHANCED EFFICACY DEMONSTRATED IN PATIENTS WITH KRAS WILD-TYPE TUMORS IN FIRST-LINE METASTATIC COLORECTAL CANCER Geneva, Switzerland | English | |
| 31/05/2008 | MERCK SERONO: ERBITUX SIGNIFICANTLY PROLONGS SURVIVAL IN FIRST-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER Geneva, Switzerland | English | |
| 30/05/2008 | MERCK SERONO RECEIVES CHMP POSITIVE OPINION FOR MARKETING AUTHORIZATION FOR ERBITUX INCLUDING 1ST-LINE COLORECTAL CANCER IN THE EUROPEAN UNION Geneva, Switzerland | English | |
| 30/05/2008 | MERCK SERONO A DÉPOSÉ LA DERNIÈRE DEMANDE DE PERMIS DE CONSTRUIRE RELATIVE AU PROJET D’EXTENSION DE SON SITE DE PRODUCTION DE CORSIER-SUR-VEVEY Genève, Suisse | German French | |
| 15/05/2008 | PROJET D’EXTENSION DU SITE DE MERCK SERONO À CORSIER-SUR-VEVEY : CONCLUSIONS DE LA NOTICE D’IMPACT SUR L’ENVIRONNEMENT Genève, Suisse | German French | |
| 05/05/2008 | UNIQUE THREE-YEAR DATA DEMONSTRATING LONG-TERM EFFICACY AND SAFETY OF RAPTIVA® IN THE TREATMENT OF PSORIASIS PUBLISHED IN THE BRITISH JOURNAL OF DERMATOLOGY Geneva, Switzerland | English German French | |
| 30/04/2008 | MERCK SERONO ANNOUNCES INITIATION OF PHASE II CLINICAL TRIAL OF ATACICEPT IN RELAPSING MULTIPLE SCLEROSIS Geneva, Switzerland | English German French | |
| 16/04/2008 | MERCK ANNOUNCES PLANNED INVESTMENT OF $50 MILLION IN RESEARCH CENTER IN THE US Geneva, Switzerland | English German French | |
| 19/03/2008 | MERCK SERONO LAUNCHES CYANOKIT® IN JAPAN Geneva, Switzerland | English German French |
| 2007 | |||
| 20/12/2007 | MERCK SERONO AND FLAMEL TO COLLABORATE ON AN EXTENDED RELEASE FORMULATION FOR THERAPEUTIC PROTEINS
Geneva, Switzerland | English German French | |
| 19/12/2007 | MERCK KGAA IDERA PHARMACEUTICALS TO COLLABORATE ON DEVELOPMENT OF TLR9 AGONISTS FOR TREATMENT OF CANCER
| English German | |
| 18/12/2007 | MERCK SERONO LAUNCHES NEW WEBSITE Geneva, Switzerland | English German French | |
| 13/12/2007 | MERCK SERONO ANNOUNCES SUPPORT OF THE MICHAEL J. FOX FOUNDATION FOR PARKINSON’S RESEARCH Geneva, Switzerland | English German French | |
| 13/12/2007 | MERCK SERONO ANNOUNCES INITIATION OF PHASE II/III CLINICAL TRIAL OF ATACICEPT IN LUPUS NEPHRITIS Geneva, Switzerland | English German French | |
| 29/11/2007 | NEW DATA HIGHLIGHT THAT TREATMENT WITH ERBITUX ALLOWS MORE RESECTIONS OF PRETREATED PATIENTS WITH METASTATIC COLORECTAL CANCER Geneva, Switzerland | English | |
| 29/11/2007 | MERCK SERONO’S CYANOKIT® APPROVED IN THE EUROPEAN UNION Geneva, Switzerland | English German French | |
| 28/11/2007 | MERCK SERONO INITIATES THE MOTION STUDY, A NEW PHASE III CLINICAL TRIAL OF SAFINAMIDE IN PARKINSON’S DISEASE
Geneva, Switzerland | English German French | |
| 14/11/2007 | STUDY PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE SHOWS ERBITUX IMPROVES SURVIVAL IN METASTATIC COLORECTAL CANCER Geneva, Switzerland | English | |
| 08/11/2007 | MERCK SERONO SUBMITS EUROPEAN MARKETING AUTHORIZATION APPLICATION FOR SAPROPTERIN AS A TREATMENT FOR HYPERPHENYLALANINEMIA Geneva, Switzerland | English German French | |
| 08/11/2007 | FDA APPROVAL OF EASYPOD®: NEW ELECTRONIC GROWTH HORMONE INJECTION DEVICE Geneva, Switzerland | English German French | |
| 31/10/2007 | MERCK SERONO AND EPFL ANNOUNCE RESEARCH PARTNERSHIP IN NEUROSCIENCE, ONCOLOGY AND DRUG DELIVERY Geneva, Switzerland | English German French | |
| 17/10/2007 | MERCK SERONO ANNOUNCES JOINT AGREEMENT WITH IMCLONE AND BRISTOL-MYERS SQUIBB FOR ERBITUX IN JAPAN Geneva, Switzerland | English | |
| 11/10/2007 | TWO-YEAR PHASE IIIB DATA SHOW THAT THE NEW FORMULATION OF REBIF® OFFERS A NEAR THREE-FOLD IMPROVEMENT IN INJECTION TOLERABILITY AND REDUCED IMMUNOGENICITY
Geneva, Switzerland | English German French | |
| 26/09/2007 | DATA REINFORCE THE VALUE OF UFT® AS AN IMPORTANT TREATMENT OPTION FOR PATIENTS WITH METASTATIC COLORECTAL CANCER Geneva, Switzerland | English | |
| 25/09/2007 | SAFETY AND EFFICACY OF ERBITUX® CONFIRMED FOR COMBINATION TRIALS Geneva, Switzerland | English | |
| 24/09/2007 | MERCK SERONO’S CYANOKIT® RECOMMENDED FOR EUROPEAN APPROVAL Geneva, Switzerland | English German | |
| 11/09/2007 | ERBITUX PHASE III STUDY – FLEX INCREASES OVERALL SURVIVAL IN FIRST-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER Geneva, Switzerland | English | |
| 05/09/2007 | STIMUVAX® THERAPEUTIC CANCER VACCINE – PHASE II DATA HIGHLIGHT THREE-YEAR SURVIVAL RESULTS FOR LUNG CANCER PATIENTS Geneva, Switzerland | English | |
| 03/09/2007 | MERCK SERONO APPLIES TO EXTEND USE OF ERBITUX® FOR 1ST-LINE COLORECTAL CANCER
Geneva, Switzerland | English | |
| 30/08/2007 | NEW FORMULATION OF MULTIPLE SCLEROSIS TREATMENT REBIF® APPROVED IN EUROPEAN UNION Geneva, Switzerland | English German French | |
| 29/08/2007 | MERCK SERONO TO RECONSIDER DEVELOPMENT OF MATUZUMAB IN METASTATIC COLORECTAL CANCER PATIENTS
Geneva, Switzerland | English | |
| 22/08/2007 | MERCK SERONO ANNOUNCES 18-MONTH SAFETY AND EFFICACY DATAOF PHASE III TRIAL OF SAFINAMIDE IN PARKINSON’S DISEASE Geneva, Switzerland | English | |
| 06/07/2007 | SQUEEZE OUT OF MERCK SERONO SHARES SUCCESSFULLY COMPLETED
Geneva, Switzerland | English German French | |
| 29/06/2007 | MERCK SERONO’S FERTILITY TREATMENT PERGOVERIS™ APPROVED IN EUROPEAN UNION Geneva, Switzerland | English German French | |
| 28/06/2007 | EUROPEAN UNION CHMP RECOMMENDS APPROVAL OF NEW FORMULATION OF MULTIPLE SCLEROSIS TREATMENT REBIF® (INTERFERON BETA-1A)
Geneva, Switzerland | English German French | |
| 19/06/2007 | MERCK SERONO AND AMBRX TO COLLABORATE ON DEVELOPMENT OF NEXT GENERATION GROWTH HORMONE PRODUCTS Geneva, Switzerland | English German French | |
| 18/06/2007 | EASYPOD™ PATIENT FRIENDLY INJECTION DEVICE RECOGNIZED BY TECHNOLOGY AWARD Geneva, Switzerland | English German French | |
| 15/06/2007 | INAUGURATION OF MERCK SERONO’S NEW GLOBAL HEAD OFFICE IN GENEVA
Geneva, Switzerland | English German French | |
| 08/06/2007 | PROMISING DATA ON COGNITIVE EFFECTS OF SAFINAMIDEIN EARLY PARKINSON’S DISEASE Geneva, Switzerland | English German French | |
| 04/06/2007 | MERCK SERONO S.A. TO TERMINATE REGISTRATION AND DUTY TO FILE REPORTS UNDER THE U.S. SECURITIES EXCHANGE ACT Geneva, Switzerland | English German French | |
| 04/06/2007 | CLOSING OF THE EXISTING SHARE-REPURCHASE PROGRAM OF UP TO CHF 750 MILLION BY JUNE 1, 2007 Geneva, Switzerland | English French | |
| 16/05/2007 | INAUGURATION DE L’ESPACE DE VIE ENFANTINE CRESCENDO Genéve, Suisse | French | |
| 02/05/2007 | PHASE III DATA ON SAFINAMIDE IN PARKINSON'S DISEASE PRESENTED AT AMERICAN ACADEMY OF NEUROLOGY 59TH ANNUAL MEETING
Geneva, Siwtzerland | English French | |
| 27/04/2007 | MERCK SERONO ANNOUNCES PRESENTATION OF PHASE III CLINICAL DATA ON SAFINAMIDE IN PARKINSON’S DISEASE AT THE AMERICAN ACADEMY OF NEUROLOGY 59TH ANNUAL MEETING Geneva, Switzerland | German French | |
| 05/04/2007 | MERCK SERONO S.A. TO VOLUNTARILY DELIST AND DEREGISTER ITS BEARER SHARES AND AMERICAN DEPOSITARY SHARES (EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS) Geneva, Switerland | English German French | |
| 21/03/2007 | MERCK SERONO CONFIRMS PREVIOUSLY ANNOUNCED 2006 FIGURES
Geneva, Switzerland | English German French | |
| 21/03/2007 | MERCK INITIATES SQUEEZE OUT PROCEDURE FOR SHARES OF MERCK SERONO S.A.
Geneva, Switzerland | English German French | |
| 01/03/2007 | MERCK KGAA ANNOUNCES SERONO PRELIMINARY FIGURES FOR 2006 Geneva, Switzerland | English German French | |
| 28/02/2007 | MERCK KGAA HOLDS NEARLY ALL VOTING RIGHTS IN MERCK SERONO S.A. Geneva, Switzerland | English | |
| 30/01/2007 | MERCK SERONO LAUNCHES EASYPOD®, FIRST ELECTRONIC GROWTH HORMONE INJECTION DEVICE
Geneva, Switzerland | English German French | |
| 24/01/2007 | MERCK SERONO HAS INITIATED THE ONWARD STUDY TO EVALUATE ORAL CLADRIBINE AS ADD-ON TREATMENT FOR MULTIPLE SCLEROSIS Geneva, Switzerland | English German French | |
| 16/01/2007 | MERCK SERONO COMPLETES PATIENT ENROLLMENT IN CLARITY PHASE III PIVOTAL CLINICAL TRIAL OF ORAL CLADRIBINE Geneva, Switzerland | English German French | |
| 16/01/2007 | MERCK SERONO ANNOUNCES POSITIVE RESULTS FROM PHASE III DIET STUDY OF PHENOPTIN FOR PHENYLKETONURIA Geneva, Switzerland | English German French | |
| 09/01/2007 | MERCK KGAA ANNOUNCES PUBLIC TENDER OFFER FOR MERCK SERONO SHARES
Darmstadt, Germany | English | |
| 08/01/2007 | MERCK SERONO IS LAUNCHED Geneva, Switzerland | English German French | |
| 05/01/2007 | MERCK KGAA ACQUIRES MARJORITY SHAREHOLDING IN SERONO S.A. Geneva, Switzerland | English |
| 2006 | |||
| 20/12/2006 | ZYMOGENETICS AND SERONO BEGIN PHASE 2 CLINICAL TRIAL WITH ATACICEPT IN RHEUMATOID ARTHRITIS
Geneva, Switzerland | English German French | |
| 18/12/2006 | MERCK KGAA: EUROPEAN ANTITRUST AUTHORITIES CLEAR ACQUISITION OF SERONO
Geneva, Switzerland | English | |
| 12/12/2006 | SERONO ANNOUNCES INITIATION OF THE REFLEX TRIAL TO EVALUATE NEW FORMULATION OF REBIF® IN PATIENTS AT RISK OF DEVELOPING MULTIPLE SCLEROSIS Geneva, Switzerland | English German French | |
| 13/11/2006 | ZYMOGENETICS AND SERONO REPORT DETAILED POSITIVE RESULTS FROM ATACICEPT PHASE 1B CLINICAL TRIAL IN PATIENTS WITH LUPUS
Seattle, USA and Geneva, Switzerland | English German French | |
| 31/10/2006 | 24-WEEK CLEAR STUDY RESULTS CONFIRM SUSTAINED EFFICACY AND SAFETY OF RAPTIVA® IN MODERATE-TO-SEVERE PSORIASIS PATIENTS WITH CO-MORBIDITIES Geneva, Switzerland | English German French | |
| 19/10/2006 | FINANCIAL TABLES Geneva, Switzerland | English | |
| 19/10/2006 | SERONO DELIVERS STRONG ADJUSTED* NET INCOME OF $183.5M IN THIRD QUARTER 2006
Geneva, Switzerland | English German French | |
| 16/10/2006 | SERONO AND NEWRON ANNOUNCE GLOBAL DEVELOPMENT AND COMMERCIALIZATION AGREEMENT FOR SAFINAMIDE Geneva, Switzerland and Milan, Italy | English German French | |
| 02/10/2006 | FINAL DATA FROM TWO PHASE II TRIALS INDICATE ACTIVITY OF ADECATUMUMAB (MT201) IN BREAST AND PROSTATE CANCER
Carlsbad, CA and Geneva, Switzerland | English German French | |
| 28/09/2006 | ONE-YEAR DATA FROM PHASE III TRIAL SHOW THAT NEW FORMULATION OF REBIF® OFFERS SUBSTANTIAL IMPROVEMENT IN TOLERABILITY AND IMMUNOGENICITY PROFILES
Madrid, Spain | English French | |
| 25/09/2006 | PUBLICATION OF INTERESTS (Art. 21 LBVM [SWISS STOCK MARKET LAW])
Geneva, Switzerland | English German French | |
| 21/09/2006 | SERONO'S ORAL CLADRIBINE FOR THE TREATMENT OF MULTIPLE SCLEROSIS AWARDED FAST TRACK STATUS BY FDA Geneva, Switzerland | English German French | |
| 21/09/2006 | MERCK KGAA TO ACQUIRE SERONO Geneva, Switzerland | English | |
| 18/09/2006 | SERONO AND SYNTONIX TO PURSUE THE DEVELOPMENT OF A LONG-ACTING, INHALEABLE FSH THERAPY TO TREAT INFERTILITY
Geneva, Switzerland and Waltham, Mass | English German French | |
| 12/09/2006 | BIOMARIN AND SERONO ANNOUNCE DATA ON PHENOPTIN IN PKU TO BE PRESENTED AT THE 56TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF HUMAN GENETIC Novato, California and Geneva, Switzerland | English | |
| 26/07/2006 | SERONO DELIVERS SECOND QUARTER EPS OF $12.92, UP 25.2% ON ADJUSTED BASIS
Geneva, Switzerland | English German French | |
| 26/07/2006 | FINANCIAL TABLES Geneva, Switzerland | English | |
| 24/07/2006 | SERONO INITIATES FIRST LARGE SCALE EUROPEAN PHARMACO-EPIDEMIOLOGICAL STUDY IN PSORIASIS TO FURTHER DOCUMENT THE DEMONSTRATED LONG-TERM SAFETY PROFILE OF RAPTIVA® Geneva, Switzerland | English German French | |
| 10/07/2006 | EUROPEAN COMMISSION APPROVES REVISION OF THERAPEUTIC INDICATION FOR REBIF®
Geneva, Switzerland | English German French | |
| 26/06/2006 | ZYMOGENETICS AND SERONO PRESENT POSITIVE RESULTS OF TACI-IG PHASE 1B TRIAL IN RHEUMATOID ARTHRITIS AT EULAR MEETING Seattle, USA and Geneva, Switzerland | English German French | |
| 22/06/2006 | COMPELLING EVIDENCE OF RAPTIVA® 12-WEEK CLEAR TRIAL DATA IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS PUBLISHED IN BRITISH JOURNAL OF DERMATOLOGY
Geneva, Switzerland | English German French | |
| 09/05/2006 | SERONO ANNOUNCES NEW APPOINTMENTS TO ITS EXECUTIVE MANAGEMENT BOARD Geneva, Switzerland | English German French | |
| 25/04/2006 | SERONO SHAREHOLDERS APPROVE RESOLUTIONS AT ANNUAL GENERAL MEETING Geneva, Switzerland | English German French | |
| 20/04/2006 | SERONO DELIVERS STRONG FIRST QUARTER 2006 WITH REVENUE GROWTH OF 16.4% IN LOCAL CURRENCIES Geneva, Switzerland | English German French | |
| 20/04/2006 | FINANCIAL TABLES Geneva, Switzerland | English | |
| 10/04/2006 | SERONO ANNOUNCES TERMINATION OF DISCUSSIONS CONCERNING A SALE OF THE COMPANY
Geneva, Switzerland | English German French | |
| 04/04/2006 | SERONO SUBMITS NEW FORMULATION OF REBIF® FOR APPROVAL IN THE UNITED STATES AND IN EUROPE
Geneva, Switzerland and Rockland, MA | ||
| 31/03/2006 | SERONO’S BOARD OF DIRECTORS TO PROPOSE AN INCREASE IN AUTHORIZED SHARE CAPITAL TO THE FORTHCOMING ANNUAL SHAREHOLDERS’ MEETING TO PROVIDE THE COMPANY WITH FINANCING CAPACITY Geneva, Switzerland | English German French | |
| 15/03/2006 | BIOMARIN AND SERONO ANNOUNCE POSITIVE RESULTS FROM PHASE 3 CLINICAL STUDY OF PHENOPTIN FOR PKU
Novato, CA and Geneva, Switzerland | English German French | |
| 06/02/2006 | SERONO'S 2005 ADJUSTED* EPS INCREASED BY 34.6% Geneva, Switzerland | English German French | |
06/02/2006 | FINANCIAL TABLES Geneva, Switzerland | English | |
| 24/01/2006 | SERONO’S GONAL-F® APPROVED IN JAPAN FOR THE TREATMENT OF MALE HYPOGONADOTROPIC HYPOGONADISM Geneva, Switzerland | English German French | |
| 09/01/2006 | SERONO COMPLETES SECOND PHASE III TRIAL OF ITS PROPRIETARY Geneva, Switzerland and Rockland, MA | English German French |
